ODI Pharma AB (publ) (NGM:ODI)
Sweden
· Delayed Price · Currency is SEK 2.100
+0.020 (0.96%)
At close: May 13, 2025
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 21.50M SEK in the twelve months ending December 31, 2024, up 2,527.19% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.29M with 15,880.34% growth.
Revenue (ttm)
21.50M
Revenue Growth
+2,527.19%
P/S Ratio
1.76
Revenue / Employee
21.50M
Employees
1
Market Cap
37.88M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 104.49B |
| Atlas Copco AB | 176.63B |
| AB Volvo | 517.43B |
| EQT AB | 30.39B |
| ASSA ABLOY AB | 152.90B |
| Skandinaviska Enskilda Banken AB | 79.55B |
| Swedbank AB | 73.90B |
| Telefonaktiebolaget LM Ericsson | 249.58B |